PF-03550096

PF-03550096 is a drug that acts as a potent agonist for the CB 2 cannabinoid receptor, with good selectivity over CB 1 having K i values of 7nM at CB 2 and 1500nM at CB 1 .

Uses your system voice; voice and rate in settings.

≈ 1 min read

Cite, export and learn8 citation formats · 8 exports · lesson and quiz

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

PF-03550096 is a drug that acts as a potent agonist for the CB 2 cannabinoid receptor, with good selectivity over CB 1 having K i values of 7nM at CB 2 and 1500nM at CB 1 . It was originally developed by Pfizer in 2008 as a medication for irritable bowel syndrome, but has only progressed to animal studies.

Text derived from https://en.wikipedia.org/w/index.php?oldid=1268766513 under CC BY-SA 4.0; modifications have been made.

Provenance

snapshot enwiki-001268766513 · captured 2025-01-11 · ledger · version history

Cite this page as: encyclopegia.org, “PF-03550096”, snapshot enwiki-001268766513. https://encyclopegia.org/a/pf-03550096

Sources cited in this revision

1 named source(s) extracted from the cited revision. A source with no author is shown by its publication; nothing is invented.